Skip to main content

Table 1 Clinical characteristics of study subjects

From: Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans

N

585

Women/Men

422/163

Age (yr)

42 (31-52)

Body Mass Index (Kg/m 2 ) a

41 (36.5-47.5)

SBP (mm/Hg)

130 (120-140)

DBP (mm/Hg)

80 (80-90)

Triglycerides (mg/dL)

113 (81-157.2)

Total Cholesterol (mg/dL)

200 (178-227.1)

HDL Cholesterol (mg/dL)

Male: 43 (38.1-49.1)

Female: 50 (44-58.5)

LDL Cholesterol (mg/dL)

122 (103.5-146.2)

ALT (U/L)

28 (20.5-43)

AST (U/L)

20 (16-26)

Fasting blood glucose (mg/dL)

90 (82-99)

Fasting blood insulin (μU/mL)

24 (16.3-35)

HOMA-IR (U)

5.1 (3.4-8.4)

ISI (U)

2.1 (1.4-3.4)

Type 2 diabetes n (%)

40 (6.8)

  1. a BMI was calculated as body weight (kg)/height (m2). Values are medians and interquartile ranges. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; HOMA-IR, homeostatic model assessment of insulin resistance; ISI, insulin sensitivity index.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X